Systemic mycoses in Mexico

被引:0
作者
Mendez-Tovar, Luis Javier [1 ]
机构
[1] Hosp Especialidades Ctr Med La Raza, Lab Invest Med Dermatol & Micolog, Ctr Med Nacl Siglo 21, Inst Mexicano Seguro Social, Mexico City 06725, DF, Mexico
来源
GACETA MEDICA DE MEXICO | 2008年 / 144卷 / 02期
关键词
systemic mycoses; histoplasmosis; coccidioidomycosis; paracoccidioidomycosis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The systemic mycoses present in Mexico are three: coccidioidomycosis, histoplasmosis and paracoccidioidomycosis. All of them are acquired by respiratory route and later, they are disseminated to diverse organs. Coccidioidomycosis is more frequent in the states of northern Mexico, where the climate and the soil rich in salts allow the development of Coccidioides immitis. The most important registers are from some communities of Coahuila and Nuevo Leon states where up to 90% of the population has had contact with the agent; this has been detected by serological tests. Histoplasmosis occurs throughout country mainly associated to manipulation of bat and bird's guano. In the last three decades its importance has increased with the AIDS pandemic. This mycosis can cause a long evolution febrile syndrome and finally death. Paracoccidiodomycosis is present in states with temperate or tropical climates such as Veracruz where the temperature and humidity, associated to the great amount of vegetal material in the soil favour the development of Paracoccidioides brasiliensis. After the lung infection this agent shows a tendency to invade lymph nodes, adrenal glands and skin. Although these infections can be lethal, they are not required as an obligatory epidemiologic inform, and therefore its real frequency in our country is unknown.
引用
收藏
页码:128 / 130
页数:3
相关论文
共 19 条
  • [1] Coccidioidomycosis and blastomycosis:: Advances in molecular diagnosis
    Bialek, R
    González, GM
    Begerow, D
    Zelck, UE
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2005, 45 (03): : 355 - 360
  • [2] PARACOCCIDIOIDOMYCOSIS - AN UPDATE
    BRUMMER, E
    CASTANEDA, E
    RESTREPO, A
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (02) : 89 - 117
  • [3] CARRADABRAVO T, 1984, REV MED IMSS, V22, P363
  • [4] GONZALEZ-OCHOA A., 1963, REV TOST SALUBRIDAD Y ENFERM TROP, V23, P81
  • [5] GONZALEZBENAVID.J, 1988, GAC MED MEX, V127, P427
  • [6] Molecular genetic approaches to the study of human pathogenic fungi
    Kobayashi, GS
    Taylor, ML
    Dei-Cas, E
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2005, 45 (03): : 353 - 354
  • [7] Mondragón-González R., 2005, Rev. argent. microbiol., V37, P135
  • [8] MORAESSILVA MRB, 1988, MYCOPATHOLOGIA, V102, P87
  • [9] PHAGOCYTOSIS OF HISTOPLASMA-CAPSULATUM YEASTS AND MICROCONIDIA BY HUMAN CULTURED MACROPHAGES AND ALVEOLAR MACROPHAGES - CELLULAR CYTOSKELETON REQUIREMENT FOR ATTACHMENT AND INGESTION
    NEWMAN, SL
    BUCHER, C
    RHODES, J
    BULLOCK, WE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01) : 223 - 230
  • [10] Orozco-Topete RD, 1998, REV INVEST CLIN, V50, P525